Price movement over the last 24 hours
Aptos vs Bio Protocol — how do they compare? Aptos trades at Rp11,162 (market cap Rp9,38T, Rp1,3T 24h volume), while Bio Protocol trades at Rp496.69 (market cap Rp1,11T, Rp317,28M 24h volume). The key difference: Aptos is far larger — about 8.5× Bio Protocol's market cap, and Aptos's circulating supply is 833M / 2,1B APT (40%) versus 2,2B / 3,3B BIO (68%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Aptos for 31 Days and Bio Protocol for 16 Days on average.
| APT | BIO | |
|---|---|---|
Market Cap | Rp9,38T | Rp1,11T |
Volume (24h) | Rp1,3T | Rp317,28M |
Circulating Supply | 833M / 2,1B APT (40%) | 2,2B / 3,3B BIO (68%) |
Typical Hold Time | 31 Days | 16 Days |
Signals from Pluang's Aura AI — not financial advice
Aptos trades at Rp11,163 with a market cap of Rp9.38T, showing neutral technical signals overall. The asset is currently between key support at Rp11,027 and resistance at Rp11,614, with mixed indicator readings - RSI_6 suggests overbought conditions while ADX_6 indicates strong trend strength. With 40% of max supply circulating and average hold time of 31 days, token distribution appears stable.
Outlook remains balanced with technical indicators showing conflicting signals. Key opportunities include potential breakout above Rp11,614 resistance, while risks include overbought RSI conditions and broader crypto market volatility. Investors should monitor volume patterns and ecosystem developments closely.
Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.
Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Aptos is a Layer 1 Proof-of-Stake (PoS) blockchain that utilizes Move, an innovative smart contract programming language based on Rust. It aims to drive mainstream adoption of web3 by enabling a robust ecosystem of decentralized applications (dApps) that address real-word user needs.
Read more on APT →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →